» Articles » PMID: 37943313

Voxel-based Morphometry in Single Subjects Without a Scanner-specific Normal Database Using a Convolutional Neural Network

Overview
Journal Eur Radiol
Specialty Radiology
Date 2023 Nov 9
PMID 37943313
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Reliable detection of disease-specific atrophy in individual T1w-MRI by voxel-based morphometry (VBM) requires scanner-specific normal databases (NDB), which often are not available. The aim of this retrospective study was to design, train, and test a deep convolutional neural network (CNN) for single-subject VBM without the need for a NDB (CNN-VBM).

Materials And Methods: The training dataset comprised 8945 T1w scans from 65 different scanners. The gold standard VBM maps were obtained by conventional VBM with a scanner-specific NDB for each of the 65 scanners. CNN-VBM was tested in an independent dataset comprising healthy controls (n = 37) and subjects with Alzheimer's disease (AD, n = 51) or frontotemporal lobar degeneration (FTLD, n = 30). A scanner-specific NDB for the generation of the gold standard VBM maps was available also for the test set. The technical performance of CNN-VBM was characterized by the Dice coefficient of CNN-VBM maps relative to VBM maps from scanner-specific VBM. For clinical testing, VBM maps were categorized visually according to the clinical diagnoses in the test set by two independent readers, separately for both VBM methods.

Results: The VBM maps from CNN-VBM were similar to the scanner-specific VBM maps (median Dice coefficient 0.85, interquartile range [0.81, 0.90]). Overall accuracy of the visual categorization of the VBM maps for the detection of AD or FTLD was 89.8% for CNN-VBM and 89.0% for scanner-specific VBM.

Conclusion: CNN-VBM without NDB provides a similar performance in the detection of AD- and FTLD-specific atrophy as conventional VBM.

Clinical Relevance Statement: A deep convolutional neural network for voxel-based morphometry eliminates the need of scanner-specific normal databases without relevant performance loss and, therefore, could pave the way for the widespread clinical use of voxel-based morphometry to support the diagnosis of neurodegenerative diseases.

Key Points: • The need of normal databases is a barrier for widespread use of voxel-based brain morphometry. • A convolutional neural network achieved a similar performance for detection of atrophy than conventional voxel-based morphometry. • Convolutional neural networks can pave the way for widespread clinical use of voxel-based morphometry.

Citing Articles

Searching for the grail: may machine learning be a road to clinical use of brain MRI segmentation?.

Quarantelli M Eur Radiol. 2023; 34(6):3575-3577.

PMID: 37975922 DOI: 10.1007/s00330-023-10438-0.

References
1.
Ashburner J, Friston K . Voxel-based morphometry--the methods. Neuroimage. 2000; 11(6 Pt 1):805-21. DOI: 10.1006/nimg.2000.0582. View

2.
Ashburner J, Friston K . Why voxel-based morphometry should be used. Neuroimage. 2001; 14(6):1238-43. DOI: 10.1006/nimg.2001.0961. View

3.
Goto M, Abe O, Hagiwara A, Fujita S, Kamagata K, Hori M . Advantages of Using Both Voxel- and Surface-based Morphometry in Cortical Morphology Analysis: A Review of Various Applications. Magn Reson Med Sci. 2022; 21(1):41-57. PMC: 9199978. DOI: 10.2463/mrms.rev.2021-0096. View

4.
Caspers J, Heeger A, Turowski B, Rubbert C . Automated age- and sex-specific volumetric estimation of regional brain atrophy: workflow and feasibility. Eur Radiol. 2020; 31(2):1043-1048. PMC: 7813701. DOI: 10.1007/s00330-020-07196-8. View

5.
Sato R, Kudo K, Udo N, Matsushima M, Yabe I, Yamaguchi A . A diagnostic index based on quantitative susceptibility mapping and voxel-based morphometry may improve early diagnosis of Alzheimer's disease. Eur Radiol. 2022; 32(7):4479-4488. DOI: 10.1007/s00330-022-08547-3. View